Skip to content
My WebMD Sign In, Sign Up

Multiple Sclerosis Health Center

Font Size

Multiple Sclerosis: Other Treatments Under Study - Topic Overview

Researchers continually search for new or better medicines to treat multiple sclerosis (MS). MS appears to be a disease in which the immune system attacks the covering of the nerves (myelin) within the brain and spinal cord. So treatments that reduce the activity of the immune system may slow the progression of the disease. Medicines that work in this manner are called immunosuppressants. They are a major focus of MS research.

Several immunosuppressants being studied or used for MS are:

Recommended Related to Multiple Sclerosis

10 Questions About Multiple Sclerosis

There are four types: Relapsing-remitting. This is the most common form. You have flare-ups followed by periods without symptoms, called recovery. Primary-progressive. With this type, you do not get the ups and downs. Your symptoms get worse over time. Secondary-progressive. You get flares and recovery periods at the start, then symptoms steadily worsen. Progressive-relapsing. This form is very rare. Symptoms worsen from the start. You experience...

Read the 10 Questions About Multiple Sclerosis article > >

  • Azathioprine (Imuran), which has shown conflicting results but may reduce the number of relapses in relapsing-remitting MS.
  • Cladribine (Leustatin), which has been used successfully against leukemia. The U.S. Food and Drug Administration (FDA) did not approve this drug for treatment of MS because of serious side effects, including death.
  • Cyclophosphamide, which some experts believe stabilizes MS without improving it. But research has shown conflicting results.
  • Methotrexate, which has also been used to treat cancer and rheumatoid arthritis. This drug may be of limited benefit in reducing the progression of MS.
  • Monoclonal antibodies, such as:
    • Alemtuzumab (Campath), which has been shown to reduce disability in relapsing-remitting MS. But the side effects of this medicine may include serious life-threatening complications.
    • Daclizumab (Zenapax), which may reduce disease activity in relapsing-remitting MS.
    • Rituximab (Rituxan), which has been shown to reduce the number of relapses in relapsing-remitting MS, but has had serious side effects, including PML.
  • Laquinimod, which is still experimental. It has been shown to reduce the number of active lesions in people with MS, as seen on MRI.

Any therapy that can be used to treat MS must be judged by how it affects a person's degree of disability. Newer studies rely on the results of MRI scans and the progression of disability to evaluate how well therapy is working.

Other medicines being studied for multiple sclerosis (MS) include firategrast.

1

WebMD Medical Reference from Healthwise

Last Updated: May 09, 2013
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Multiple Sclerosis: Other Treatments Under Study Topics

Today on WebMD

brain and teriflunomide molecule
ARTICLE
neural fiber
ARTICLE
 
white blood cells
VIDEO
linguini with asparagus and mushrooms
ARTICLE
 
brain scan
ARTICLE
worried woman
ARTICLE
 
person writin in a notebook
ARTICLE
couple embracing
ARTICLE
 
man with cane
SLIDESHOW
skull and neck xray
ARTICLE
 
Stressed man
ARTICLE
doctor feeling patients neck
ASSESSMENT
 

WebMD Special Sections